{"meshTags":["Triazoles","Cell Line, Tumor","Proto-Oncogene Proteins c-met","Molecular Structure","Humans","Click Chemistry","Structure-Activity Relationship","Protein Kinase Inhibitors","Models, Molecular"],"meshMinor":["Triazoles","Cell Line, Tumor","Proto-Oncogene Proteins c-met","Molecular Structure","Humans","Click Chemistry","Structure-Activity Relationship","Protein Kinase Inhibitors","Models, Molecular"],"genes":["Met","HGF","MDCK"],"organisms":["9606"],"publicationTypes":["Journal Article","Research Support, Non-U.S. Gov\u0027t"],"abstract":"The use of Cu(I)-catalyzed azide-alkyne 1,3-dipolar cycloaddition permitted the synthesis of a new compound that is able to inhibit the HGF-induced scattering of MDCK (epithelial cells) and in vitro tumorigenesis of H1437 (non-small-cell lung cancer) and GTL-16 (human gastric carcinoma). In agreement with biochemical and biological results, docking studies within the ATP binding site of Met suggested for the new synthesized compound a binding mode similar to that of the active compound Triflorcas previously reported.","title":"\u0027Click\u0027 synthesis of a triazole-based inhibitor of Met functions in cancer cells.","pubmedId":"22738633"}